Cardinal Health launches Kendall SCD SmartFlow™ Compression System
Rhea-AI Summary
Cardinal Health (NYSE: CAH) announced the U.S. launch of its Kendall SCD SmartFlow™ Compression System, an advanced solution for preventing deep vein thrombosis and pulmonary embolism. The system features Vascular Refill Detection technology that customizes compression cycles to match patient's unique vascular refill time, increasing blood flow efficiency. Notable features include Patient Sensing™ Technology that automatically detects therapy application and alerts for incorrect usage. The system will be available internationally in early 2025.
Positive
- Launch of new medical device expanding product portfolio
- Technology improvements over previous compression systems
- Expanded indication to treat pain and swelling
- International market expansion planned for 2025
Negative
- None.
Insights
The launch of the Kendall SCD SmartFlow™ Compression System represents an incremental improvement in Cardinal Health's medical device portfolio, but its market impact is likely to be modest. While the system offers enhanced features like Vascular Refill Detection technology and Patient Sensing™ Technology, these are evolutionary rather than revolutionary improvements to existing compression therapy solutions.
The key differentiator is the expanded indication for treating pain and swelling, which could moderately increase the addressable market. The system's ability to deliver more compression cycles through customized timing may improve clinical outcomes, but this is unlikely to dramatically shift market share or significantly impact Cardinal Health's revenue stream, given that compression devices are already well-established in the healthcare setting.
The international expansion planned for early 2025 provides some additional growth potential, though the impact on CAH's overall financial performance will likely be given the company's diverse revenue streams and
Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention
"We're proud to introduce the reimagined Kendall SCD device to our customers for consistent, effective and reliable compression therapy, providing clinicians with efficiencies so they can focus more of their time on direct patient care," said Steve Marshall, senior vice president, Cardinal Health Global Product Marketing. "We're happy to offer an easy-to-use device that now has the indication to treat pain and swelling, which can be common and debilitating symptoms for patients with insufficient blood flow."
The Kendall SCD SmartFlow™ Compression System leverages Vascular Refill Detection (VRD) technology with a sequential, gradient and circumferential sleeve design to move more blood per hour than uniform compression2. The VRD technology adjusts and customizes compression cycles to match a patient's unique vascular refill time, helping the patient receive more compression cycles over time and ultimately reducing stasis2. The circumferential sleeve design allows therapy to be applied regardless of sleeve and tubing position, while the gradient pressure pattern maximizes blood flow.
Complementing the VRD technology are additional clinical benefits and features, including proprietary Patient Sensing™ Technology that automatically detects if compression therapy is being applied and will activate an alert if the system does not detect a patient present or correct use of the sleeves on the patient's legs.
"For 40 years, the Cardinal Health Kendall SCD compression portfolio has served as a trusted solution with healthcare providers, protecting their patients from experiencing VTE events," Marshall said. "The new, intuitively designed system demonstrates our continued commitment to innovation within the Kendall portfolio and builds on our long-time capabilities in compression therapy."
The Cardinal Health™ Kendall SCD SmartFlow™ Compression System is now available for health systems in the
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.
Contacts
Media: Brittany Julian, brittany.julian@cardinalhealth.com
Investors: Matt Sims, matt.sims@cardinalhealth.com
References:
1. Kakkos SK, Nicolaides AN, Griffin M, Geroulakos G. Comparison of two intermittent pneumatic compression systems. A hemodynamic study. Int Angiol. 2005;24(4):330-5.
2. Griffin M, et al. Comparison of three intermittent pneumatic compression systems in patients with varicose veins: A haemodynamic study. Int Angiol. 2007 Jun;26:158-64.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-launches-kendall-scd-smartflow-compression-system-302310136.html
SOURCE Cardinal Health
FAQ
When will Cardinal Health (CAH) launch the Kendall SCD SmartFlow Compression System internationally?
What are the main features of Cardinal Health's (CAH) new Kendall SCD SmartFlow System?
What conditions does Cardinal Health's (CAH) new compression system treat?
